stockrow
Saturday 7 November 2026
Export HCA’s income statement to Excel — free account
HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.59%
- EPS
- +23.8%
- Free cash flow
- −0.77%
- Total debt
- +13.4%
Quarter to September 2026, against a year earlier
496.04
11.44
−2.25%
Follow HCA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
16.45 | 13.66 | 14.51 | 12.65 | 12.09 | 15.05 | 14.68 | 11.69 | 15.07 | 10.17 |
Piotroski F-Score |
7 | 8 | 7 | 5 | 7 | 6 | 7 | 7 | 6 | 8 |
P/S ratio |
1.46 | 1.10 | 1.15 | 1.17 | 1.41 | 1.08 | 0.98 | 0.93 | 0.74 | 0.69 |
Altman Z-Score |
2.80 | 2.54 | 2.54 | 2.54 | 2.89 | 2.46 | 2.35 | 2.29 | 2.08 | 2.10 |
Altman Z″-Score (non-manufacturers) |
0.92 | 1.22 | 1.36 | 1.49 | 1.81 | 1.66 | 1.40 | 1.13 | 1.10 | 1.05 |
P/FCF ratio |
14.35 | 13.76 | 16.00 | 17.11 | 15.43 | 8.70 | 14.64 | 13.56 | 13.45 | 9.87 |
Beneish M-Score |
(2.87) | (2.73) | (2.66) | (2.57) | (2.46) | (2.97) | (2.71) | (2.71) | (2.73) | (2.81) |
P/Operating CF |
46.79 | 30.33 | 28.05 | 27.94 | 34.00 | (15.53) | 20.13 | 19.87 | 18.70 | 16.81 |
Dividend Safety Score |
78 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.00 | 139.86 | 70.75 | 0.00 | 55.79 | 19.24 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.06 | 1.68 | 1.75 | 1.79 | 1.98 | 1.65 | 1.63 | 1.62 | 1.48 | 1.43 |
EV/EBITDA |
9.98 | 8.53 | 8.91 | 8.91 | 9.17 | 8.43 | 8.45 | 8.41 | 7.84 | 7.19 |
EV/Operating CF |
12.33 | 11.29 | 12.05 | 12.65 | 12.97 | 9.19 | 10.99 | 11.17 | 11.93 | 10.49 |
EV/FCF |
20.26 | 21.05 | 24.25 | 26.12 | 21.59 | 13.26 | 24.26 | 23.70 | 26.86 | 20.50 |
Quick Ratio |
0.73 | 0.84 | 0.86 | 0.99 | 1.00 | 1.02 | 1.03 | 0.96 | 1.17 | 1.11 |
Current Ratio |
0.97 | 1.08 | 1.18 | 1.38 | 1.41 | 1.42 | 1.44 | 1.35 | 1.62 | 1.56 |
Net Debt/EBITDA |
2.91 | 2.95 | 3.03 | 3.07 | 2.61 | 2.90 | 3.35 | 3.60 | 3.91 | 3.72 |
Debt/Assets |
76.57% | 72.31% | 70.44% | 72.63% | 68.15% | 65.29% | 74.84% | 83.71% | 90.34% | 92.94% |
Debt/Equity |
(16.78) | 77.53 | 37.35 | (521.70) | 23.22 | 10.72 | (59.68) | (11.25) | (6.62) | (5.57) |
Asset Turnover |
1.26 | 1.22 | 1.20 | 1.17 | 1.20 | 1.11 | 1.22 | 1.23 | 1.24 | 1.25 |
Operating CF/Net income |
1.86 | 1.83 | 1.80 | 1.51 | 1.29 | 2.46 | 2.17 | 1.79 | 2.45 | 1.96 |
Capex/Depreciation |
(1.39) | (1.46) | (1.52) | (1.47) | (1.24) | (1.03) | (1.58) | (1.55) | (1.39) | (1.38) |
Interest Coverage |
5.36 | 5.13 | 4.98 | 5.23 | 6.25 | 4.62 | 3.98 | 3.80 | 3.61 | 3.66 |
| (612.27%) | 713.31% | 1,062.21% | 797.03% | 317.55% | 322.65% | (201.26%) | (95.72%) | (41.70%) | (49.49%) | |
| 11.28% | 9.95% | 9.65% | 10.94% | 14.16% | 8.11% | 8.32% | 9.99% | 6.30% | 8.69% | |
ROIC |
17.64% | 15.86% | 15.18% | 15.33% | 17.68% | 14.24% | 13.95% | 14.18% | 13.95% | 15.57% |
Return on Tangible Assets |
22.19% | 18.79% | 17.48% | 19.25% | 24.82% | 13.99% | 13.40% | 16.91% | 10.21% | 14.74% |
Average Days of Receivables |
52.47 | 55.58 | 55.95 | 53.88 | 50.29 | 49.94 | 52.47 | 53.09 | 54.41 | 51.25 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
43.46% | 44.15% | 45.39% | 45.96% | 45.58% | 46.33% | 45.89% | 45.90% | 45.99% | 45.55% |
Intangible Assets out of Total Assets |
0.17 | 0.17 | 0.18 | 0.18 | 0.19 | 0.18 | 0.18 | 0.20 | 0.20 | 0.20 |
Share Based Compensation of Revenue |
0.53% | 0.51% | 0.40% | 0.57% | 0.75% | 0.70% | 0.68% | 0.57% | 0.62% | 0.60% |
Graham Net Nets |
(0.43) | (0.55) | (0.54) | (0.55) | (0.43) | (0.58) | (0.68) | (0.74) | (0.97) | (1.06) |
Graham Number |
0.00 | 32.57 | 40.76 | 0.00 | 46.93 | 45.85 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
6.08% | 7.32% | 6.89% | 7.91% | 8.27% | 6.65% | 6.81% | 8.56% | 6.64% | 9.83% |
Free Cash Flow Yield |
6.97% | 7.26% | 6.25% | 5.84% | 6.48% | 11.50% | 6.83% | 7.38% | 7.43% | 10.13% |
Revenue per Share |
319.78 | 273.02 | 238.50 | 207.45 | 181.72 | 152.34 | 150.45 | 134.40 | 120.38 | 108.16 |
Operating CF per Share |
53.45 | 40.66 | 34.62 | 29.35 | 27.71 | 27.29 | 22.28 | 19.47 | 14.98 | 14.74 |
Capex per Share |
(20.91) | (18.85) | (17.42) | (15.14) | (11.06) | (8.38) | (12.19) | (10.29) | (8.32) | (7.20) |
Free Cash Flow per Share |
32.54 | 21.81 | 17.21 | 14.21 | 16.65 | 18.91 | 10.09 | 9.18 | 6.65 | 7.54 |
Cash per Share |
4.40 | 7.47 | 3.43 | 3.13 | 4.49 | 5.30 | 1.82 | 1.45 | 2.02 | 1.68 |
Shareholders Equity per Share |
(11.72) | 2.15 | 3.89 | (0.25) | 4.61 | 8.55 | (1.66) | (8.40) | (13.79) | (14.68) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(11.72) | 2.15 | 3.89 | (0.25) | 4.61 | 8.55 | (1.66) | (8.40) | (13.79) | (14.68) |
Free Cash Flow |
7,692.00 | 5,639.00 | 4,687.00 | 4,127.00 | 5,382.00 | 6,397.00 | 3,444.00 | 3,188.00 | 2,411.00 | 2,893.00 |
Working Capital |
(567.00) | 1,237.00 | 2,272.00 | 3,741.00 | 3,960.00 | 3,629.00 | 3,439.00 | 2,644.00 | 3,819.00 | 3,252.00 |
Capital Expenditures |
(4,944.00) | (4,875.00) | (4,744.00) | (4,395.00) | (3,577.00) | (2,835.00) | (4,158.00) | (3,573.00) | (3,015.00) | (2,760.00) |
Net Current Asset Value |
(47,708.00) | (42,544.00) | (40,224.00) | (38,868.00) | (35,711.00) | (32,265.00) | (34,427.00) | (31,912.00) | (31,611.00) | (30,305.00) |
EV/EBIT |
12.94 | 11.23 | 11.78 | 11.85 | 11.87 | 11.60 | 11.50 | 11.32 | 10.61 | 9.48 |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.08 | 0.08 | 0.07 | 0.07 |
Price to Operating Income |
9.16 | 7.34 | 7.77 | 7.76 | 8.48 | 7.60 | 6.95 | 6.48 | 5.31 | 4.57 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.11 | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
Cash ROIC |
17.18% | 12.39% | 11.27% | 10.60% | 14.34% | 17.92% | 10.20% | 10.49% | 8.37% | 10.96% |
Accounts Receivable Turnover |
6.99 | 6.82 | 6.89 | 7.09 | 7.76 | 7.14 | 7.25 | 7.02 | 7.08 | 7.08 |
Accounts Payable Turnover |
2.54 | 2.53 | 2.34 | 2.24 | 2.48 | 2.60 | 3.09 | 2.98 | 2.97 | 3.09 |
Inventory Turnover |
6.71 | 5.72 | 4.84 | 4.62 | 4.73 | 4.32 | 4.74 | 4.67 | 4.76 | 4.71 |
Average Days of Payables |
149.60 | 145.12 | 156.03 | 165.11 | 158.27 | 154.17 | 125.02 | 121.78 | 130.02 | 122.04 |
Days of Inventory on Hand |
53.05 | 58.98 | 74.50 | 80.55 | 76.46 | 88.32 | 79.58 | 81.85 | 78.48 | 79.13 |
Average Receivables |
10,809.00 | 10,354.50 | 9,424.50 | 8,493.00 | 7,573.00 | 7,215.50 | 7,084.50 | 6,645.00 | 6,163.50 | 5,857.50 |
Average Payables |
4,467.50 | 4,254.50 | 4,236.00 | 4,175.00 | 3,823.00 | 3,220.00 | 2,741.00 | 2,591.50 | 2,462.00 | 2,244.00 |
Average Inventory |
1,695.00 | 1,879.50 | 2,044.50 | 2,027.00 | 2,005.50 | 1,937.00 | 1,790.50 | 1,652.50 | 1,538.00 | 1,471.00 |
Average Assets |
60,116.50 | 57,862.00 | 54,324.50 | 51,590.00 | 49,116.00 | 46,274.00 | 42,132.50 | 37,900.00 | 35,175.50 | 33,251.00 |
Average Common Equity |
(1,108.00) | 807.50 | 493.50 | 708.00 | 2,190.50 | 1,163.50 | (1,741.50) | (3,956.50) | (5,314.00) | (5,839.50) |
Columns are period end dates · fundamentals updated 2 Nov 2026